|Mr. Timothy George Dixon||Chairman, CEO, Pres & Member of CTE Advisory Board||174k||N/A||1958|
|Mr. Gerry B. Berg||VP, CFO & Director||174k||N/A||1947|
|Dr. Feng Lin||Chief Scientific Officer||N/A||N/A||N/A|
|Dr. James Drew Veltmeyer||Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board||N/A||N/A||N/A|
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship product is ProJuvenol, a synergistic blend of complex anti-aging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality. The company also focuses on the manufacture of devices to treat patients with obstructive sleep apnea. Therapeutic Solutions International, Inc. was founded in 2010 and is based in Oceanside, California.
Therapeutic Solutions International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.